0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Animal Stem Cell Therapy Market Insights, Forecast to 2025
Published Date: March 2019
|
Report Code: QYRE-Othe-273
Home | Market Reports | Health | Health Foundations & Medical Research
Global Animal Stem Cell Therapy Market Insights Forecast to 2025

Global Animal Stem Cell Therapy Market Insights, Forecast to 2025

Code: QYRE-Othe-273
Report
March 2019
114 Pages
QYResearch
Region: Global,
Description
Table of Content

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The classification of animal stem cell therapy includes dogs, horses and others. And the proportion of dogs in 2017 is about 50.42%, and the proportion is in increasing trend from 2013 to 2017.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58.63% in 2017. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15.17% in 2017.
The global Animal Stem Cell Therapy market is valued at 16 million US$ in 2018 and will reach 200 million US$ by the end of 2025, growing at a CAGR of 37.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Animal Stem Cell Therapy market based on company, product type, end user and key regions.

This report studies the global market size of Animal Stem Cell Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Animal Stem Cell Therapy in these regions.
This research report categorizes the global Animal Stem Cell Therapy market by top players/brands, region, type and end user. This report also studies the global Animal Stem Cell Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medivet Biologics LLC
VETSTEM BIOPHARMA
J-ARM
U.S. Stem Cell, Inc
VetCell Therapeutics
Celavet Inc.
Magellan Stem Cells
Kintaro Cells Power
Animal Stem Care
Animal Cell Therapies
Cell Therapy Sciences
Animacel

Market size by Product
Dogs
Horses
Others
Market size by End User
Veterinary Hospitals
Research Organizations

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Animal Stem Cell Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Animal Stem Cell Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Animal Stem Cell Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Animal Stem Cell Therapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Animal Stem Cell Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Animal Stem Cell Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Animal Stem Cell Therapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Animal Stem Cell Therapy Market Size Growth Rate by Product
1.4.2 Dogs
1.4.3 Horses
1.4.4 Others
1.5 Market by End User
1.5.1 Global Animal Stem Cell Therapy Market Size Growth Rate by End User
1.5.2 Veterinary Hospitals
1.5.3 Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Animal Stem Cell Therapy Market Size
2.1.1 Global Animal Stem Cell Therapy Revenue 2014-2025
2.1.2 Global Animal Stem Cell Therapy Sales 2014-2025
2.2 Animal Stem Cell Therapy Growth Rate by Regions
2.2.1 Global Animal Stem Cell Therapy Sales by Regions
2.2.2 Global Animal Stem Cell Therapy Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Animal Stem Cell Therapy Sales by Manufacturers
3.1.1 Animal Stem Cell Therapy Sales by Manufacturers
3.1.2 Animal Stem Cell Therapy Sales Market Share by Manufacturers
3.1.3 Global Animal Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Animal Stem Cell Therapy Revenue by Manufacturers
3.2.1 Animal Stem Cell Therapy Revenue by Manufacturers (2014-2019)
3.2.2 Animal Stem Cell Therapy Revenue Share by Manufacturers (2014-2019)
3.3 Animal Stem Cell Therapy Price by Manufacturers
3.4 Animal Stem Cell Therapy Manufacturing Base Distribution, Product Types
3.4.1 Animal Stem Cell Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Animal Stem Cell Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Animal Stem Cell Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Animal Stem Cell Therapy Sales by Product
4.2 Global Animal Stem Cell Therapy Revenue by Product
4.3 Animal Stem Cell Therapy Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Animal Stem Cell Therapy Breakdown Data by End User

6 North America
6.1 North America Animal Stem Cell Therapy by Countries
6.1.1 North America Animal Stem Cell Therapy Sales by Countries
6.1.2 North America Animal Stem Cell Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Animal Stem Cell Therapy by Product
6.3 North America Animal Stem Cell Therapy by End User

7 Europe
7.1 Europe Animal Stem Cell Therapy by Countries
7.1.1 Europe Animal Stem Cell Therapy Sales by Countries
7.1.2 Europe Animal Stem Cell Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Animal Stem Cell Therapy by Product
7.3 Europe Animal Stem Cell Therapy by End User

8 Asia Pacific
8.1 Asia Pacific Animal Stem Cell Therapy by Countries
8.1.1 Asia Pacific Animal Stem Cell Therapy Sales by Countries
8.1.2 Asia Pacific Animal Stem Cell Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Animal Stem Cell Therapy by Product
8.3 Asia Pacific Animal Stem Cell Therapy by End User

9 Central & South America
9.1 Central & South America Animal Stem Cell Therapy by Countries
9.1.1 Central & South America Animal Stem Cell Therapy Sales by Countries
9.1.2 Central & South America Animal Stem Cell Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Animal Stem Cell Therapy by Product
9.3 Central & South America Animal Stem Cell Therapy by End User

10 Middle East and Africa
10.1 Middle East and Africa Animal Stem Cell Therapy by Countries
10.1.1 Middle East and Africa Animal Stem Cell Therapy Sales by Countries
10.1.2 Middle East and Africa Animal Stem Cell Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Animal Stem Cell Therapy by Product
10.3 Middle East and Africa Animal Stem Cell Therapy by End User

11 Company Profiles
11.1 Medivet Biologics LLC
11.1.1 Medivet Biologics LLC Company Details
11.1.2 Company Business Overview
11.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Medivet Biologics LLC Animal Stem Cell Therapy Products Offered
11.1.5 Medivet Biologics LLC Recent Development
11.2 VETSTEM BIOPHARMA
11.2.1 VETSTEM BIOPHARMA Company Details
11.2.2 Company Business Overview
11.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Products Offered
11.2.5 VETSTEM BIOPHARMA Recent Development
11.3 J-ARM
11.3.1 J-ARM Company Details
11.3.2 Company Business Overview
11.3.3 J-ARM Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 J-ARM Animal Stem Cell Therapy Products Offered
11.3.5 J-ARM Recent Development
11.4 U.S. Stem Cell, Inc
11.4.1 U.S. Stem Cell, Inc Company Details
11.4.2 Company Business Overview
11.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 U.S. Stem Cell, Inc Animal Stem Cell Therapy Products Offered
11.4.5 U.S. Stem Cell, Inc Recent Development
11.5 VetCell Therapeutics
11.5.1 VetCell Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 VetCell Therapeutics Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 VetCell Therapeutics Animal Stem Cell Therapy Products Offered
11.5.5 VetCell Therapeutics Recent Development
11.6 Celavet Inc.
11.6.1 Celavet Inc. Company Details
11.6.2 Company Business Overview
11.6.3 Celavet Inc. Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Celavet Inc. Animal Stem Cell Therapy Products Offered
11.6.5 Celavet Inc. Recent Development
11.7 Magellan Stem Cells
11.7.1 Magellan Stem Cells Company Details
11.7.2 Company Business Overview
11.7.3 Magellan Stem Cells Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Magellan Stem Cells Animal Stem Cell Therapy Products Offered
11.7.5 Magellan Stem Cells Recent Development
11.8 Kintaro Cells Power
11.8.1 Kintaro Cells Power Company Details
11.8.2 Company Business Overview
11.8.3 Kintaro Cells Power Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Kintaro Cells Power Animal Stem Cell Therapy Products Offered
11.8.5 Kintaro Cells Power Recent Development
11.9 Animal Stem Care
11.9.1 Animal Stem Care Company Details
11.9.2 Company Business Overview
11.9.3 Animal Stem Care Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Animal Stem Care Animal Stem Cell Therapy Products Offered
11.9.5 Animal Stem Care Recent Development
11.10 Animal Cell Therapies
11.10.1 Animal Cell Therapies Company Details
11.10.2 Company Business Overview
11.10.3 Animal Cell Therapies Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Animal Cell Therapies Animal Stem Cell Therapy Products Offered
11.10.5 Animal Cell Therapies Recent Development
11.11 Cell Therapy Sciences
11.12 Animacel

12 Future Forecast
12.1 Animal Stem Cell Therapy Market Forecast by Regions
12.1.1 Global Animal Stem Cell Therapy Sales Forecast by Regions 2019-2025
12.1.2 Global Animal Stem Cell Therapy Revenue Forecast by Regions 2019-2025
12.2 Animal Stem Cell Therapy Market Forecast by Product
12.2.1 Global Animal Stem Cell Therapy Sales Forecast by Product 2019-2025
12.2.2 Global Animal Stem Cell Therapy Revenue Forecast by Product 2019-2025
12.3 Animal Stem Cell Therapy Market Forecast by End User
12.4 North America Animal Stem Cell Therapy Forecast
12.5 Europe Animal Stem Cell Therapy Forecast
12.6 Asia Pacific Animal Stem Cell Therapy Forecast
12.7 Central & South America Animal Stem Cell Therapy Forecast
12.8 Middle East and Africa Animal Stem Cell Therapy Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Animal Stem Cell Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India

RELATED REPORTS

Global Neurodegenerative Diseases Drug Market Insights and Forecast to 2028
Global Neurodegenerative Diseases Drug Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-33M1920
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Leuprolide Market Insights and Forecast to 2028
Global Leuprolide Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-12Y5964
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Non GLP Acute Toxicology Market Insights Forecast to 2028
Global Non-GLP Acute Toxicology Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-2C4572
Fri Apr 22 00:00:00 UTC 2022

Add to Cart

Global Marginal Zone Lymphoma Treatment Market Insights Forecast to 2028
Global Marginal Zone Lymphoma Treatment Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-35D5642
Thu Apr 21 00:00:00 UTC 2022

Add to Cart